Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/7255
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Human wild-type SEDL protein functionally complements yeast Trs20p but some naturally occurring SEDL mutants do not
Author: Gecz, J.
Shaw, M.
Bellon, J.
de Barros Lopes, M.
Citation: Gene, 2003; 320(1-2):137-144
Publisher: Elsevier Science BV
Issue Date: 2003
ISSN: 0378-1119
1879-0038
Statement of
Responsibility: 
Jozef Gécz, Marie A. Shaw, Jennifer R. Bellon, Miguel de Barros Lopes
Abstract: X-linked spondyloepiphyseal dysplasia tarda (SEDT, or SEDL) is a primary skeletal dysplasia affecting mostly spinal vertebral bodies and epiphyses. Previously, we have identified the SEDL gene and determined the spectrum of 21 different SEDL causing mutations. The SEDL gene is a highly conserved gene with an as yet unknown function. The yeast SEDL protein ortholog, Trs20p, has been isolated as a member of a large multi-protein complex ( approximately 10 proteins) called transport protein particle (TRAPP), which is involved in endoplasmic reticulum (ER)-to-Golgi transport. While the SEDL gene mutations cause a tissue-specific (epiphyses) and relatively mild phenotype, the Trs20p function is essential for the yeast cell. We now provide evidence that recombinant human SEDL protein is able to functionally complement the Saccharomyces cerevisiae TRS20 (TRAPP subunit 20 gene) knockout mutant. This finding strongly supports the speculated conserved nature of the SEDL/Trs20p function. To shed further light on the SEDL/Trs20p protein function, five different naturally occurring SEDL gene mutations have been tested in complementation studies. While two truncation mutations (157delAT and C271T) and one missense mutation (G139T) were unable to rescue the trs20Delta lethal phenotype, two other missense mutations (C218T and T389A) did complement trs20Delta. Interestingly, there is no obvious correlation between the nature and position of the SEDL mutation and the clinical severity of the disorder among the human SEDL patients. Although the identification of complementing SEDL gene mutations may suggest the existence of subtle phenotypic differences among SEDL patients, it might also point towards the identification of SEDL protein residues/domains specific for normal, vertebrate bone growth.
Keywords: Humans; Saccharomyces cerevisiae; Glucose; Carrier Proteins; Membrane Transport Proteins; Saccharomyces cerevisiae Proteins; Membrane Proteins; Vesicular Transport Proteins; Protein Subunits; Transcription Factors; Genetic Complementation Test; Cell Division; Amino Acid Sequence; Sequence Homology, Amino Acid; Genotype; Phenotype; Mutation
RMID: 0020031016
DOI: 10.1016/S0378-1119(03)00819-9
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.